Loading…
Reported covered position: Health Policy Dir., Leg. Asst., Leg. Corr., Front Office Coordinator, Staff Asst. Sen. Blackburn
How to read the money
Income and expense are whole-filing amounts associated with this lobbyist, not personal compensation or an allocated share.
No topic inference: each bill number appears in source LDA issue text assigned to this lobbyist.
Maintaining Investments in New Innovation Act
Client: NOVARTIS · Firm: BGR GOVERNMENT AFFAIRS
Provide strategic counsel and advocacy for issues related to policies impacting the pharmaceutical industry generally including drug shortages, patientout of pocket costs, supply chain, PBM policies, kidney care policies, Inflation Reduction Act (IRA) implementation issues, the Maintaining Investments in New Innovation (MINI) Act H.R.1672, tariffs, biopharma innovation policies, regulatory/FDA policies and EPIC Act
Maintaining Investments in New Innovation Act
Client: NOVARTIS · Firm: BGR GOVERNMENT AFFAIRS
Specific issues are shown only where the LDA source assigned them to this lobbyist. Targets apply to the associated filing.
STRYKER CORPORATION via BGR GOVERNMENT AFFAIRS
2026 · third_quarter · Q3
Provide guidance and advocacy with regard to regulations and legislation that could impact the medical device industry generally, and Stryker Corporation specifically.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
MATRIX MEDICAL NETWORK via BGR GOVERNMENT AFFAIRS
2026 · third_quarter · Q3
Source: Senate LDA
| APPLIED BIOLOGICS |
| 9 |
| 2025–2026 |
| GRADY HEALTH SYSTEM | 9 | 2025–2026 |
| NYU LANGONE HEALTH | 9 | 2025–2026 |
| PFIZER, INC. | 9 | 2025–2026 |
| SCP-HEALTH | 9 | 2025–2026 |
| U.S. ACUTE CARE SOLUTIONS, LLC | 9 | 2025–2026 |
| INDUCTIVEHEALTH INFORMATICS | 8 | 2025–2026 |
| IOWA PRIMARY CARE ASSOCIATION (NATIONAL PRIMARY CARE ASSOCIATION HUB) | 8 | 2025–2026 |
| NATIONAL ALLIANCE FOR CARE AT HOME | 8 | 2025–2026 |
| SELLERS DORSEY | 8 | 2025–2026 |
| U.S. ANESTHESIA PARTNERS, INC. | 8 | 2025–2026 |
| ADVOCATE HEALTH | 7 | 2025–2026 |
| BIOTECHNOLOGY INNOVATION ORGANIZATION | 7 | 2025–2026 |
| BREAKTHROUGH T1D (F/K/A JDRF) | 7 | 2025–2026 |
| CENTENE CORPORATION | 7 | 2025–2026 |
| EDWARDS LIFESCIENCES LLC | 7 | 2025–2026 |
| FINDHELP | 7 | 2025–2026 |
| GLAXOSMITHKLINE, INC. | 7 | 2025–2026 |
| LUMEXA IMAGING, INC. (FKA US RADIOLOGY SPECIALISTS) | 7 | 2025–2026 |
| MATRIX MEDICAL NETWORK | 7 | 2025–2026 |
| NOVARTIS | 7 | 2025–2026 |
| OAK STREET HEALTH D/B/A CVS HEALTH | 7 | 2025–2026 |
| PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA | 7 | 2025–2026 |
| RADIOLOGY PARTNERS | 7 | 2025–2026 |
| SENIOR CARE PHARMACY COALITION | 7 | 2025–2026 |
| ShiftKey, LLC | 7 | 2025–2026 |
| Vaxcyte, Inc. | 7 | 2025–2026 |
| WELBEHEALTH | 7 | 2025–2026 |
| COLORECTAL CANCER ALLIANCE | 6 | 2025–2026 |
| TEXAS ESSENTIAL HEALTHCARE PARTNERSHIPS | 6 | 2025–2026 |
| TRANSMEDICS | 6 | 2025–2026 |
| AKEBIA THERAPEUTICS, INC. | 5 | 2025–2026 |
| HELLO HEART, INC | 5 | 2026 |
| REAL TIME MEDICAL SYSTEMS | 5 | 2025–2026 |
| DIGNITY AND WELLNESS PATIENT SOLUTIONS, LLC | 4 | 2025 |
| FEDERATION OF AMERICAN HOSPITALS | 4 | 2026 |
| MONTANA HEALTH SOLUTIONS, INC. | 4 | 2026 |
| QUOTE VELOCITY | 4 | 2025 |
| SWORD HEALTH | 4 | 2025–2026 |
| ADVANCED MEDICAL TECHNOLOGY ASSOCIATION | 3 | 2026 |
| ALKERMES, INC. | 3 | 2026 |
| CURANA HEALTH, INC. | 3 | 2026 |
| KIDNEY CARE PARTNERS | 3 | 2025–2026 |
| NATIONAL COMMUNITY PHARMACISTS ASSOCIATION | 3 | 2026 |
| PHI HEALTH, LLC, D/B/A PHI AIR MEDICAL | 3 | 2026 |
| RAI SERVICES COMPANY | 3 | 2026 |
| STRYKER CORPORATION | 3 | 2026 |
| TEAMHEALTH | 3 | 2026 |
| VITAE HEALTH SYSTEMS | 3 | 2026 |
| AMERICAN ACADEMY OF DERMATOLOGY ASSOCIATION | 2 | 2026 |
| DELCATH SYSTEMS, INC. | 2 | 2026 |
| DEXCOM | 2 | 2026 |
| AMGEN, INC. | 1 | 2026 |
Provide strategic counsel and advocacy for issues related to policies impacting the pharmaceutical industry generally including drug shortages, patientout of pocket costs, supply chain, PBM policies, kidney care policies, Inflation Reduction Act (IRA) implementation issues, the Maintaining Investments in New Innovation (MINI) Act H.R.1672, tariffs, biopharma innovation policies, regulatory/FDA policies, EPIC Act; Most Favored Nation (MFN) policy, drug pricing policies
Maintaining Investments in New Innovation Act
Client: NOVARTIS · Firm: BGR GOVERNMENT AFFAIRS
Provide strategic counsel and advocacy for issues related to policies impacting the pharmaceutical industry generally including drug shortages, patientout of pocket costs, supply chain, PBM policies, kidney care policies, Inflation Reduction Act (IRA) implementation issues, the Maintaining Investments in New Innovation (MINI) Act H.R.1672, tariffs, biopharma innovation policies, regulatory/FDA policies and EPIC Act
Maintaining Investments in New Innovation Act
Client: NOVARTIS · Firm: BGR GOVERNMENT AFFAIRS
Provide strategic counsel and advocacy for issues related to policies impacting the pharmaceutical industry generally including drug shortages, patientout of pocket costs, supply chain, PBM policies, kidney care policies, Inflation Reduction Act (IRA) implementation issues, the Maintaining Investments in New Innovation (MINI) Act H.R.1672, tariffs, biopharma innovation policies, regulatory/FDA policies and EPIC Act
Maintaining Investments in New Innovation Act
Client: NOVARTIS · Firm: BGR GOVERNMENT AFFAIRS
Provide strategic counsel and advocacy for issues related to policies impacting the pharmaceutical industry generally including drug shortages, patientout of pocket costs, supply chain, PBM policies, kidney care policies, Inflation Reduction Act (IRA) implementation issues, the Maintaining Investments in New Innovation (MINI) Act H.R.1672, tariffs, biopharma innovation policies, regulatory/FDA policies, EPIC Act; Most Favored Nation (MFN) policy, drug pricing policies
Maintaining Investments in New Innovation Act
Client: NOVARTIS · Firm: BGR GOVERNMENT AFFAIRS
Provide strategic counsel and advocacy for issues related to policies impacting the pharmaceutical industry generally including drug shortages, patientout of pocket costs, supply chain, PBM policies, kidney care policies, Inflation Reduction Act (IRA) implementation issues, the Maintaining Investments in New Innovation (MINI) Act H.R.1672, tariffs, biopharma innovation policies, regulatory/FDA policies, EPIC Act; Most Favored Nation (MFN) policy, drug pricing policies
Preserving Patient Access to Long-Term Care Pharmacies Act
Client: SENIOR CARE PHARMACY COALITION · Firm: BGR GOVERNMENT AFFAIRS
Legislation and regulations affecting the long-term care pharmacy industry and guidance on H.R. 5031/ S.3159 Preserving Patient Access to Long-Term Care Pharmacies Act
Preserving Patient Access to Long-Term Care Pharmacies Act
Client: SENIOR CARE PHARMACY COALITION · Firm: BGR GOVERNMENT AFFAIRS
Legislation and regulations affecting the long-term care pharmacy industry and guidance on H.R. 5031/ S.3159 Preserving Patient Access to Long-Term Care Pharmacies Act
Preserving Patient Access to Long-Term Care Pharmacies Act
Client: SENIOR CARE PHARMACY COALITION · Firm: BGR GOVERNMENT AFFAIRS
Legislation and regulations affecting the long-term care pharmacy industry and guidance on H.R. 5031/ S.3159 Preserving Patient Access to Long-Term Care Pharmacies Act
Preserving Patient Access to Long-Term Care Pharmacies Act
Client: SENIOR CARE PHARMACY COALITION · Firm: BGR GOVERNMENT AFFAIRS
Legislation and regulations affecting the long-term care pharmacy industry and guidance on H.R. 5031/ S.3159 Preserving Patient Access to Long-Term Care Pharmacies Act
Preserving Patient Access to Long-Term Care Pharmacies Act
Client: SENIOR CARE PHARMACY COALITION · Firm: BGR GOVERNMENT AFFAIRS
Legislation and regulations affecting the long-term care pharmacy industry and guidance on H.R. 5031/ S.3159 Preserving Patient Access to Long-Term Care Pharmacies Act
Preserving Patient Access to Long-Term Care Pharmacies Act
Client: SENIOR CARE PHARMACY COALITION · Firm: BGR GOVERNMENT AFFAIRS
Legislation and regulations affecting the long-term care pharmacy industry and guidance on H.R. 5031/ S.3159 Preserving Patient Access to Long-Term Care Pharmacies Act
Restore Protections for Dialysis Patients Act
Client: KIDNEY CARE PARTNERS · Firm: BGR GOVERNMENT AFFAIRS
Provide guidance, and strategic counsel on federal regulatory policy and legislative issues affecting the quality of kidney care and treatment including the ESRD Prospective Payment System Regulation and the Chronic Kidney Disease Improvement in Research and Treatment Act, Restore Protections for Dialysis Patients Act (H.R. 8594/S. 4750) and other bills impacting kidney care.
Restore Protections for Dialysis Patients Act
Client: KIDNEY CARE PARTNERS · Firm: BGR GOVERNMENT AFFAIRS
Provide guidance, and strategic counsel on federal regulatory policy and legislative issues affecting the quality of kidney care and treatment including the ESRD Prospective Payment System Regulation and the Chronic Kidney Disease Improvement in Research and Treatment Act, Restore Protections for Dialysis Patients Act (H.R. 8594/S. 4750) and other bills impacting kidney care.
Maintaining Investments in New Innovation Act
Client: NOVARTIS · Firm: BGR GOVERNMENT AFFAIRS
Provide strategic counsel and advocacy for issues related to policies impacting the pharmaceutical industry generally including drug shortages, patientout of pocket costs, supply chain, PBM policies, kidney care policies, Inflation Reduction Act (IRA) implementation issues, the Maintaining Investments in New Innovation (MINI) Act H.R.1672, tariffs, biopharma innovation policies, regulatory/FDA policies and EPIC Act
Maintaining Investments in New Innovation Act
Client: NOVARTIS · Firm: BGR GOVERNMENT AFFAIRS
Provide strategic counsel and advocacy for issues related to policies impacting the pharmaceutical industry generally including drug shortages, patientout of pocket costs, supply chain, PBM policies, kidney care policies, Inflation Reduction Act (IRA) implementation issues, the Maintaining Investments in New Innovation (MINI) Act H.R.1672, tariffs, biopharma innovation policies, regulatory/FDA policies, EPIC Act; Most Favored Nation (MFN) policy, drug pricing policies
Maintaining Investments in New Innovation Act
Client: NOVARTIS · Firm: BGR GOVERNMENT AFFAIRS
Provide strategic counsel and advocacy for issues related to policies impacting the pharmaceutical industry generally including drug shortages, patientout of pocket costs, supply chain, PBM policies, kidney care policies, Inflation Reduction Act (IRA) implementation issues, the Maintaining Investments in New Innovation (MINI) Act H.R.1672, tariffs, biopharma innovation policies, regulatory/FDA policies and EPIC Act
Maintaining Investments in New Innovation Act
Client: NOVARTIS · Firm: BGR GOVERNMENT AFFAIRS
Provide strategic counsel and advocacy for issues related to policies impacting the pharmaceutical industry generally including drug shortages, patientout of pocket costs, supply chain, PBM policies, kidney care policies, Inflation Reduction Act (IRA) implementation issues, the Maintaining Investments in New Innovation (MINI) Act H.R.1672, tariffs, biopharma innovation policies, regulatory/FDA policies and EPIC Act
Maintaining Investments in New Innovation Act
Client: NOVARTIS · Firm: BGR GOVERNMENT AFFAIRS
Provide strategic counsel and advocacy for issues related to policies impacting the pharmaceutical industry generally including drug shortages, patientout of pocket costs, supply chain, PBM policies, kidney care policies, Inflation Reduction Act (IRA) implementation issues, the Maintaining Investments in New Innovation (MINI) Act H.R.1672, tariffs, and biopharma innovation policies.
Maintaining Investments in New Innovation Act
Client: NOVARTIS · Firm: BGR GOVERNMENT AFFAIRS
Provide strategic counsel and advocacy for issues related to policies impacting the pharmaceutical industry generally including drug shortages, patientout of pocket costs, supply chain, PBM policies, kidney care policies, Inflation Reduction Act (IRA) implementation issues, the Maintaining Investments in New Innovation (MINI) Act H.R.1672, tariffs, and biopharma innovation policies.
Maintaining Investments in New Innovation Act
Client: NOVARTIS · Firm: BGR GOVERNMENT AFFAIRS
Provide strategic counsel and advocacy for issues related to policies impacting the pharmaceutical industry generally including drug shortages, patientout of pocket costs, supply chain, PBM policies, kidney care policies, Inflation Reduction Act (IRA) implementation issues, the Maintaining Investments in New Innovation (MINI) Act H.R.1672, tariffs, biopharma innovation policies, regulatory/FDA policies and EPIC Act
Maintaining Investments in New Innovation Act
Client: NOVARTIS · Firm: BGR GOVERNMENT AFFAIRS
Provide strategic counsel and advocacy for issues related to policies impacting the pharmaceutical industry generally including drug shortages, patientout of pocket costs, supply chain, PBM policies, kidney care policies, Inflation Reduction Act (IRA) implementation issues, the Maintaining Investments in New Innovation (MINI) Act H.R.1672, tariffs, biopharma innovation policies, regulatory/FDA policies, EPIC Act; Most Favored Nation (MFN) policy, drug pricing policies
Preserving Patient Access to Long-Term Care Pharmacies Act
Client: SENIOR CARE PHARMACY COALITION · Firm: BGR GOVERNMENT AFFAIRS
Legislation and regulations affecting the long-term care pharmacy industry and guidance on H.R. 5031/ S.3159 Preserving Patient Access to Long-Term Care Pharmacies Act
Preserving Patient Access to Long-Term Care Pharmacies Act
Client: SENIOR CARE PHARMACY COALITION · Firm: BGR GOVERNMENT AFFAIRS
Legislation and regulations affecting the long-term care pharmacy industry and guidance on H.R. 5031 Preserving Patient Access to Long-Term Care Pharmacies Act
Preserving Patient Access to Long-Term Care Pharmacies Act
Client: SENIOR CARE PHARMACY COALITION · Firm: BGR GOVERNMENT AFFAIRS
Legislation and regulations affecting the long-term care pharmacy industry and guidance on H.R. 5031/ S.3159 Preserving Patient Access to Long-Term Care Pharmacies Act
Restore Protections for Dialysis Patients Act
Client: KIDNEY CARE PARTNERS · Firm: BGR GOVERNMENT AFFAIRS
Provide guidance, and strategic counsel on federal regulatory policy and legislative issues affecting the quality of kidney care and treatment including the ESRD Prospective Payment System Regulation and the Chronic Kidney Disease Improvement in Research and Treatment Act, Restore Protections for Dialysis Patients Act (H.R. 8594/S. 4750) and other bills impacting kidney care.
Restore Protections for Dialysis Patients Act
Client: KIDNEY CARE PARTNERS · Firm: BGR GOVERNMENT AFFAIRS
Provide guidance, and strategic counsel on federal regulatory policy and legislative issues affecting the quality of kidney care and treatment including the ESRD Prospective Payment System Regulation and the Chronic Kidney Disease Improvement in Research and Treatment Act, Restore Protections for Dialysis Patients Act (H.R. 8594/S. 4750) and other bills impacting kidney care.
Restore Protections for Dialysis Patients Act
Client: KIDNEY CARE PARTNERS · Firm: BGR GOVERNMENT AFFAIRS
Provide guidance, and strategic counsel on federal regulatory policy and legislative issues affecting the quality of kidney care and treatment including the ESRD Prospective Payment System Regulation and the Chronic Kidney Disease Improvement in Research and Treatment Act, Restore Protections for Dialysis Patients Act (H.R. 8594/S. 4750) and other bills impacting kidney care.
Restore Protections for Dialysis Patients Act
Client: KIDNEY CARE PARTNERS · Firm: BGR GOVERNMENT AFFAIRS
Provide guidance, and strategic counsel on federal regulatory policy and legislative issues affecting the quality of kidney care and treatment including the ESRD Prospective Payment System Regulation and the Chronic Kidney Disease Improvement in Research and Treatment Act, Restore Protections for Dialysis Patients Act (H.R. 8594/S. 4750) and other bills impacting kidney care.
Provide strategic counsel and guidance on issues impacting the clinical services industry generally, and Matrix Medical Network specifically as well as issues relating to MA risk adjustment.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Office of Management & Budget (OMB), SENATE, White House Office
BREAKTHROUGH T1D (F/K/A JDRF) via BGR GOVERNMENT AFFAIRS
2026 · third_quarter · Q3
Provide strategic counsel and advocate on issues related to Type 1 Diabetes policy
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
GRADY HEALTH SYSTEM via BGR GOVERNMENT AFFAIRS
2026 · third_quarter · Q3
Provide strategic counsel and policy advocacy related to federal payment and policy issues and government funding impacting hospitals generally and Grady Health System specifically
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Office of Management & Budget (OMB), SENATE, U.S. Postal Service (USPS)
APPLIED BIOLOGICS via BGR GOVERNMENT AFFAIRS
2026 · third_quarter · Q3
Advocate on issues related to Medicare coverage
Filing targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, White House Office
VAXCYTE, INC. via BGR GOVERNMENT AFFAIRS
2026 · third_quarter · Q3
Provide strategic counsel and advocate on issues related to vaccine development
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
NYU LANGONE HEALTH via BGR GOVERNMENT AFFAIRS
2026 · third_quarter · Q3
Provide strategic counsel and policy analysis related to federal payment and policy issues and government funding impacting hospitals generally and NYU Langone Health specifically
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, White House Office
ACADEMY OF NUTRITION AND DIETETICS via BGR GOVERNMENT AFFAIRS
2026 · third_quarter · Q3
Provide strategic counsel and advocate on issues related to health care coverage for Medical Nutritional Therapy and Intensive behavior health and other priorities for the Academy of Nutrition and Dietetics
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
SCP-HEALTH via BGR GOVERNMENT AFFAIRS
2026 · third_quarter · Q3
Provide strategic guidance and counsel on policy issues impacting emergency medicine and issues related to acute unscheduled care including physician fee schedule
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
AKEBIA THERAPEUTICS, INC. via BGR GOVERNMENT AFFAIRS
2026 · third_quarter · Q3
Provide strategic guidance and counsel on issues impacting the biopharmaceutical industry and legislation to provide greater access to kidney care.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
U.S. ACUTE CARE SOLUTIONS, LLC via BGR GOVERNMENT AFFAIRS
2026 · third_quarter · Q3
Provided strategic counsel on matters before HHS and the Congress, including surprise medical billing and Medicare payment.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
AMERICAN SOCIETY OF GENE AND CELL THERAPY via BGR GOVERNMENT AFFAIRS
2026 · third_quarter · Q3
Strategic advice and counsel on issues impacting gene and cell therapy development and access
Filing targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
WALGREEN CO. via BGR GOVERNMENT AFFAIRS
2026 · third_quarter · Q3
Provide policy analysis, strategic advice and direct advocacy support to Walgreens related to public policy priorities for the retail pharmacy industry
Filing targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), SENATE, White House Office
EDWARDS LIFESCIENCES LLC via BGR GOVERNMENT AFFAIRS
2026 · third_quarter · Q3
Provide analysis and strategic advocacy support services to Edwards Lifesciences public policy priorities, including FDA regulatory and CMS coverage and reimbursement issue
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
BIOTECHNOLOGY INNOVATION ORGANIZATION via BGR GOVERNMENT AFFAIRS
2026 · third_quarter · Q3
Advise and advocate on client's behalf regarding ongoing public policy concerns impacting the innovative biotechnology industry in Congress and throughout the Administration
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
CENTENE CORPORATION via BGR GOVERNMENT AFFAIRS
2026 · third_quarter · Q3
Strategic guidance and counsel related to Medicare, Medicaid, and the insurance market.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
RAI SERVICES COMPANY via BGR GOVERNMENT AFFAIRS
2026 · third_quarter · Q3
Provide monitoring, analysis, advise and support services related to legislative and administrative policies impacting the tobacco industry
Filing targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Office of Management & Budget (OMB), SENATE
ADVOCATE HEALTH via BGR GOVERNMENT AFFAIRS
2026 · third_quarter · Q3
Provide strategic counsel and advocate on health care policy, including matters impacting the hospital industry and federal appropriations
Provide strategic counsel and advocate on health care policy, including matters impacting the hospital industry and federal appropriations
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
U.S. ANESTHESIA PARTNERS, INC. via BGR GOVERNMENT AFFAIRS
2026 · third_quarter · Q3
Provided strategic counsel on matters before HHS and the Congress, including surprise medical billing and Medicare payment.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
ADVANCED MEDICAL TECHNOLOGY ASSOCIATION via BGR GOVERNMENT AFFAIRS
2026 · third_quarter · Q3
Provide guidance and strategic advice regarding regulation and coverage of medical devices, including diagnostic tests, in addition to supply chain matters
Filing targets: Bureau of Industry and Security (BIS), Commerce, Dept of (DOC), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Intl Trade Administration (ITA), SENATE, Treasury, Dept of, U.S. Trade Representative (USTR), White House Office
SENIOR CARE PHARMACY COALITION via BGR GOVERNMENT AFFAIRS
2026 · third_quarter · Q3
Legislation and regulations affecting the long-term care pharmacy industry and guidance on H.R. 5031/ S.3159 Preserving Patient Access to Long-Term Care Pharmacies Act
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, White House Office
SHIFTKEY, LLC via BGR GOVERNMENT AFFAIRS
2026 · third_quarter · Q3
Provide strategic counsel and advocate on issues related to healthcare workforce and technology and independent contractor classification
Filing targets: HOUSE OF REPRESENTATIVES, Labor, Dept of (DOL), SENATE, Veterans Affairs, Dept of (VA)
ALKERMES, INC. via BGR GOVERNMENT AFFAIRS
2026 · third_quarter · Q3
Provide strategic counsel and advocate on issues related to the biopharmaceutical industry generally, and Alkermes, Inc. specifically
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
NOVARTIS via BGR GOVERNMENT AFFAIRS
2026 · third_quarter · Q3
Provide strategic counsel and advocacy for issues related to policies impacting the pharmaceutical industry generally including drug shortages, patientout of pocket costs, supply chain, PBM policies, kidney care policies, Inflation Reduction Act (IRA) implementation issues, the Maintaining Investments in New Innovation (MINI) Act H.R.1672, tariffs, biopharma innovation policies, regulatory/FDA policies and EPIC Act
Provide strategic counsel and advocacy for issues related to policies impacting the pharmaceutical industry generally including drug shortages, patientout of pocket costs, supply chain, PBM policies, kidney care policies, Inflation Reduction Act (IRA) implementation issues, the Maintaining Investments in New Innovation (MINI) Act H.R.1672, tariffs, biopharma innovation policies, regulatory/FDA policies, EPIC Act; Most Favored Nation (MFN) policy, drug pricing policies
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
INDUCTIVEHEALTH INFORMATICS via BGR GOVERNMENT AFFAIRS
2026 · third_quarter · Q3
Provide strategic counsel and advocate on issues related to expanding support for modern disease and syndromic surveillance, immunization, and chronic disease infrastructure and technology.
Filing targets: Centers For Disease Control & Prevention (CDC), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
SELLERS DORSEY via BGR GOVERNMENT AFFAIRS
2026 · third_quarter · Q3
Strategic guidance and counsel on federal healthcare reform legislation activity and implementation; Medicaid
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, White House Office
PFIZER, INC via BGR GOVERNMENT AFFAIRS
2026 · third_quarter · Q3
Provide guidance and strategic counsel with regard to regulations and legislation that could impact the pharmaceutical industry generally and/or Pfizer specifically.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
AMGEN INC. via BGR GOVERNMENT AFFAIRS
2026 · third_quarter · Q3
Provide advice and strategic counsel with regard to matters that could impact biopharmaceutical manufacturers generally and Amgen specifically, including Medicare Part D, Medicare Part B, Health Care Reform, Medicaid, FDA regulatory issues, and corporate tax reform.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA via BGR GOVERNMENT AFFAIRS
2026 · third_quarter · Q3
Advise and advocate on clients behalf regarding ongoing public policy concerns impacting the innovative biopharmaceutical industry in Congress and throughout the Administration.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
GLAXOSMITHKLINE, INC via BGR GOVERNMENT AFFAIRS
2026 · third_quarter · Q3
Strategic guidance and advocacy on health care related issues to include: healthcare reform, HIV/AIDS, bio-defense, Medicare/Medicaid and FDA
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
AMERICAN ACADEMY OF DERMATOLOGY ASSOCIATION via BGR GOVERNMENT AFFAIRS
2026 · third_quarter · Q3
Provide strategic counsel and advocate on issues related to physician payment.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, White House Office
CURANA HEALTH, INC. via BGR GOVERNMENT AFFAIRS
2026 · third_quarter · Q3
Provide strategic counsel and advocate on issues related to the Physician Fee Schedule
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Office of Management & Budget (OMB), SENATE
TEAMHEALTH via BGR GOVERNMENT AFFAIRS
2026 · third_quarter · Q3
Provide strategic counsel and advocate on issues related to the Physician Fee Schedule
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Office of Management & Budget (OMB), SENATE
VITAE HEALTH SYSTEMS via BGR GOVERNMENT AFFAIRS
2026 · third_quarter · Q3
Provide strategic counsel and advocate on issues related to the Physician Fee Schedule.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Office of Management & Budget (OMB), SENATE
PHI HEALTH, LLC, D/B/A PHI AIR MEDICAL via BGR GOVERNMENT AFFAIRS
2026 · third_quarter · Q3
Provide strategic counsel and advocate on issues related to ambulance legislative and regulatory issues.
Provide strategic counsel and advocate on issues related to ambulance legislative and regulatory issues.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Labor, Dept of (DOL), SENATE
NATIONAL COMMUNITY PHARMACISTS ASSOCIATION via BGR GOVERNMENT AFFAIRS
2026 · third_quarter · Q3
Provide strategic counsel and advocate on issues related to health care legislative and regulatory issues.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
DEXCOM via BGR GOVERNMENT AFFAIRS
2026 · third_quarter · Q3
Provide strategic counsel and advocate on issues related to Medicare coverage and regulatory policy.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
WELBEHEALTH via BGR GOVERNMENT AFFAIRS
2026 · third_quarter · Q3
Provide strategic counsel and advocate on issues related Medicares Program of All-Inclusive Care for the Elderly (PACE)
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, White House Office
MONTANA HEALTH SOLUTIONS, INC. via BGR GOVERNMENT AFFAIRS
2026 · third_quarter · Q3
Provide strategic counsel and advocate on issues related to home and community-based services
Provide strategic counsel and advocate on issues related to home and community-based services
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, White House Office
DELCATH SYSTEMS, INC. via BGR GOVERNMENT AFFAIRS
2026 · third_quarter · Q3
Provide strategic counsel and advocate on issues related to sustainable reimbursement policy
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
STAMFORD HEALTH via BGR GOVERNMENT AFFAIRS
2026 · third_quarter · Q3
Provide strategic counsel and policy analysis related to federal payment and policy issues and government funding impacting hospitals generally and Stamford Health specifically
THE CHILDREN'S HOSPITAL OF PHILADELPHIA via BGR GOVERNMENT AFFAIRS
2026 · third_quarter · Q3
Provide strategic counsel and policy analysis related to federal payment and policy issues and government funding impacting hospitals generally and The Children's Hospital of Philadelphia specifically
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
HELLO HEART, INC via BGR GOVERNMENT AFFAIRS
2026 · third_quarter · Q3
Provide strategic counsel and advocate on issues related to healthcare policy
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, White House Office
IOWA PRIMARY CARE ASSOCIATION (NATIONAL PRIMARY CARE ASSOCIATION HUB) via BGR GOVERNMENT AFFAIRS
2026 · third_quarter · Q3
Provide strategic counsel and advocate on federal policy issues impacting community health centers
Filing targets: Centers For Medicare and Medicaid Services (CMS), Health & Human Services, Dept of (HHS)
NATIONAL ALLIANCE FOR CARE AT HOME via BGR GOVERNMENT AFFAIRS
2026 · third_quarter · Q3
Provide strategic counsel and advocate on issues related to home health, home care and hospice policy
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Office of Management & Budget (OMB), SENATE, White House Office
FEDERATION OF AMERICAN HOSPITALS via BGR GOVERNMENT AFFAIRS
2026 · third_quarter · Q3
Provide strategic counsel and advocate on issues related to health policy and hospitals
Provide strategic counsel and advocate on issues related to health policy and hospitals
Filing targets: HOUSE OF REPRESENTATIVES, Office of Management & Budget (OMB), SENATE
ALLIANCE FOR REGENERATIVE MEDICINE via BGR GOVERNMENT AFFAIRS
2026 · third_quarter · Q3
Provide strategic guidance and advocacy on issues related to regulation of, access to, and reimbursement for regenerative medicine products, and any other issues related to the Alliance for Regenerative Medicine specifically.
Filing targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Office of Management & Budget (OMB), SENATE, White House Office
TEXAS ESSENTIAL HEALTHCARE PARTNERSHIPS via BGR GOVERNMENT AFFAIRS
2026 · third_quarter · Q3
Provide strategic counsel and policy advocacy related to to health care funding, access, and delivery, Medicaid financing and reimbursement
Filing targets: Centers For Medicare and Medicaid Services (CMS), Health & Human Services, Dept of (HHS), Office of Management & Budget (OMB), SENATE, White House Office
COLORECTAL CANCER ALLIANCE via BGR GOVERNMENT AFFAIRS
2026 · third_quarter · Q3
Provide strategic counsel and advocate on issues related to colorectal cancer research and funding
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, White House Office
REAL TIME MEDICAL SYSTEMS via BGR GOVERNMENT AFFAIRS
2026 · third_quarter · Q3
Provide strategic counsel related to federal health care policy impacting nursing facilities and assisted living settings.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
FINDHELP via BGR GOVERNMENT AFFAIRS
2026 · third_quarter · Q3
Provide strategic counsel and advocacy on federal health policy related to social care programs.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Office of Management & Budget (OMB), SENATE, Veterans Affairs, Dept of (VA), White House Office
LUMEXA IMAGING, INC. (FKA US RADIOLOGY SPECIALISTS) via BGR GOVERNMENT AFFAIRS
2026 · third_quarter · Q3
Provided strategic counsel on matters before HHS and the Congress, including surprise medical billing and Medicare payment.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
RADIOLOGY PARTNERS via BGR GOVERNMENT AFFAIRS
2026 · third_quarter · Q3
Provided strategic counsel on matters before HHS and the Congress, including surprise medical billing and Medicare payment.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
OAK STREET HEALTH D/B/A CVS HEALTH via BGR GOVERNMENT AFFAIRS
2026 · third_quarter · Q3
Provide strategic counsel and advocacy on issues impacting value-based primary care centers for Medicare beneficiaries generally, and Oak Street Health specifically
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
AMERICAN ACADEMY OF DERMATOLOGY ASSOCIATION via BGR GOVERNMENT AFFAIRS
2026 · third_quarter · RR
Provide strategic counsel and advocate on issues related to physician payment.
STAMFORD HEALTH via BGR GOVERNMENT AFFAIRS
2026 · second_quarter · Q2
Provide strategic counsel and policy analysis related to federal payment and policy issues and government funding impacting hospitals generally and Stamford Health specifically
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
THE CHILDREN'S HOSPITAL OF PHILADELPHIA via BGR GOVERNMENT AFFAIRS
2026 · second_quarter · Q2
Provide strategic counsel and policy analysis related to federal payment and policy issues and government funding impacting hospitals generally and The Children's Hospital of Philadelphia specifically
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
ALLIANCE FOR REGENERATIVE MEDICINE via BGR GOVERNMENT AFFAIRS
2026 · second_quarter · Q2
Provide strategic guidance and advocacy on issues related to regulation of, access to, and reimbursement for regenerative medicine products, and any other issues related to the Alliance for Regenerative Medicine specifically.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
REAL TIME MEDICAL SYSTEMS via BGR GOVERNMENT AFFAIRS
2026 · second_quarter · Q2
Provide strategic counsel related to federal health care policy impacting nursing facilities and assisted living settings.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
FINDHELP via BGR GOVERNMENT AFFAIRS
2026 · second_quarter · Q2
Provide strategic counsel and advocacy on federal health policy related to social care programs.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Office of Management & Budget (OMB), SENATE, Veterans Affairs, Dept of (VA), White House Office
LUMEXA IMAGING, INC. (FKA US RADIOLOGY SPECIALISTS) via BGR GOVERNMENT AFFAIRS
2026 · second_quarter · Q2
Provided strategic counsel on matters before HHS and the Congress, including surprise medical billing and Medicare payment.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
RADIOLOGY PARTNERS via BGR GOVERNMENT AFFAIRS
2026 · second_quarter · Q2
Provided strategic counsel on matters before HHS and the Congress, including surprise medical billing and Medicare payment.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
OAK STREET HEALTH D/B/A CVS HEALTH via BGR GOVERNMENT AFFAIRS
2026 · second_quarter · Q2
Provide strategic counsel and advocacy on issues impacting value-based primary care centers for Medicare beneficiaries generally, and Oak Street Healthspecifically
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
IOWA PRIMARY CARE ASSOCIATION (NATIONAL PRIMARY CARE ASSOCIATION HUB) via BGR GOVERNMENT AFFAIRS
2026 · second_quarter · Q2
Provide strategic counsel and advocate on federal policy issues impacting community health centers
Filing targets: Centers For Medicare and Medicaid Services (CMS), Health & Human Services, Dept of (HHS), White House Office
STRYKER CORPORATION via BGR GOVERNMENT AFFAIRS
2026 · second_quarter · Q2
Provide guidance and advocacy with regard to regulations and legislation that could impact the medical device industry generally, and Stryker Corporation specifically.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
MATRIX MEDICAL NETWORK via BGR GOVERNMENT AFFAIRS
2026 · second_quarter · Q2
Provide strategic counsel and guidance on issues impacting the clinical services industry generally, and Matrix Medical Network specifically as well as issues relating to MA risk adjustment.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Office of Management & Budget (OMB), SENATE, White House Office
NATIONAL COMMUNITY PHARMACISTS ASSOCIATION via BGR GOVERNMENT AFFAIRS
2026 · second_quarter · Q2
Provide strategic counsel and advocate on issues related to health care legislative and regulatory issues.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
CURANA HEALTH, INC. via BGR GOVERNMENT AFFAIRS
2026 · second_quarter · Q2
Provide strategic counsel and advocate on issues related to the Physician Fee Schedule
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Office of Management & Budget (OMB), SENATE
SCP-HEALTH via BGR GOVERNMENT AFFAIRS
2026 · second_quarter · Q2
Provide strategic guidance and counsel on policy issues impacting emergency medicine and issues related to acute unscheduled care including physician fee schedule
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
TEAMHEALTH via BGR GOVERNMENT AFFAIRS
2026 · second_quarter · Q2
Provide strategic counsel and advocate on issues related to the Physician Fee Schedule
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Office of Management & Budget (OMB), SENATE
AKEBIA THERAPEUTICS, INC. via BGR GOVERNMENT AFFAIRS
2026 · second_quarter · Q2
Provide strategic guidance and counsel on issues impacting the biopharmaceutical industry and legislation to provide greater access to kidney care.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
VITAE HEALTH SYSTEMS via BGR GOVERNMENT AFFAIRS
2026 · second_quarter · Q2
Provide strategic counsel and advocate on issues related to the Physician Fee Schedule.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Office of Management & Budget (OMB), SENATE
PHI HEALTH, LLC, D/B/A PHI AIR MEDICAL via BGR GOVERNMENT AFFAIRS
2026 · second_quarter · Q2
Provide strategic counsel and advocate on issues related to ambulance legislative and regulatory issues.
Provide strategic counsel and advocate on issues related to ambulance legislative and regulatory issues.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Labor, Dept of (DOL), SENATE
U.S. ACUTE CARE SOLUTIONS, LLC via BGR GOVERNMENT AFFAIRS
2026 · second_quarter · Q2
Provided strategic counsel on matters before HHS and the Congress, including surprise medical billing and Medicare payment.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
AMERICAN SOCIETY OF GENE AND CELL THERAPY via BGR GOVERNMENT AFFAIRS
2026 · second_quarter · Q2
Strategic advice and counsel on issues impacting gene and cell therapy development and access
Filing targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
WALGREEN CO. via BGR GOVERNMENT AFFAIRS
2026 · second_quarter · Q2
Provide policy analysis, strategic advice and direct advocacy support to Walgreens related to public policy priorities for the retail pharmacy industry
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
DEXCOM via BGR GOVERNMENT AFFAIRS
2026 · second_quarter · Q2
Provide strategic counsel and advocate on issues related to Medicare coverage and regulatory policy.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
EDWARDS LIFESCIENCES LLC via BGR GOVERNMENT AFFAIRS
2026 · second_quarter · Q2
Provide analysis and strategic advocacy support services to Edwards Lifesciences public policy priorities, including FDA regulatory and CMS coverage and reimbursement issue
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
NATIONAL ALLIANCE FOR CARE AT HOME via BGR GOVERNMENT AFFAIRS
2026 · second_quarter · Q2
Provide strategic counsel and advocate on issues related to home health, home care and hospice policy
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Office of Management & Budget (OMB), SENATE, White House Office
TEXAS ESSENTIAL HEALTHCARE PARTNERSHIPS via BGR GOVERNMENT AFFAIRS
2026 · second_quarter · Q2
Provide strategic counsel and policy advocacy related to to health care funding, access, and delivery, Medicaid financing and reimbursement
Filing targets: Centers For Medicare and Medicaid Services (CMS), Health & Human Services, Dept of (HHS), Office of Management & Budget (OMB), SENATE, White House Office
BIOTECHNOLOGY INNOVATION ORGANIZATION via BGR GOVERNMENT AFFAIRS
2026 · second_quarter · Q2
Advise and advocate on client's behalf regarding ongoing public policy concerns impacting the innovative biotechnology industry in Congress and throughout the Administration
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
CENTENE CORPORATION via BGR GOVERNMENT AFFAIRS
2026 · second_quarter · Q2
Strategic guidance and counsel related to Medicare, Medicaid, and the insurance market.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
MONTANA HEALTH SOLUTIONS, INC. via BGR GOVERNMENT AFFAIRS
2026 · second_quarter · Q2
Provide strategic counsel and advocate on issues related to home and community-based services
Provide strategic counsel and advocate on issues related to home and community-based services
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, White House Office
DELCATH SYSTEMS, INC. via BGR GOVERNMENT AFFAIRS
2026 · second_quarter · Q2
Provide strategic counsel and advocate on issues related to sustainable reimbursement policy
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
GRADY HEALTH SYSTEM via BGR GOVERNMENT AFFAIRS
2026 · second_quarter · Q2
Provide strategic counsel and policy advocacy related to federal payment and policy issues and government funding impacting hospitals generally and Grady Health System specifically
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Office of Management & Budget (OMB), SENATE
RAI SERVICES COMPANY via BGR GOVERNMENT AFFAIRS
2026 · second_quarter · Q2
Provide monitoring, analysis, advise and support services related to legislative and administrative policies impacting the tobacco industry
Filing targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE
APPLIED BIOLOGICS via BGR GOVERNMENT AFFAIRS
2026 · second_quarter · Q2
Advocate on issues related to Medicare coverage
Filing targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, White House Office
VAXCYTE, INC. via BGR GOVERNMENT AFFAIRS
2026 · second_quarter · Q2
Provide strategic counsel and advocate on issues related to vaccine development
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
HELLO HEART, INC via BGR GOVERNMENT AFFAIRS
2026 · second_quarter · Q2
Provide strategic counsel and advocate on issues related to healthcare policy
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, White House Office
FEDERATION OF AMERICAN HOSPITALS via BGR GOVERNMENT AFFAIRS
2026 · second_quarter · Q2
Provide strategic counsel and advocate on issues related to health policy and hospitals
Provide strategic counsel and advocate on issues related to health policy and hospitals
Filing targets: HOUSE OF REPRESENTATIVES, Office of Management & Budget (OMB), SENATE
U.S. ANESTHESIA PARTNERS, INC. via BGR GOVERNMENT AFFAIRS
2026 · second_quarter · Q2
Provided strategic counsel on matters before HHS and the Congress, including surprise medical billing and Medicare payment.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
NYU LANGONE HEALTH via BGR GOVERNMENT AFFAIRS
2026 · second_quarter · Q2
Provide strategic counsel and policy analysis related to federal payment and policy issues and government funding impacting hospitals generally and NYU Langone Health specifically
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, White House Office
ADVANCED MEDICAL TECHNOLOGY ASSOCIATION via BGR GOVERNMENT AFFAIRS
2026 · second_quarter · Q2
Provide guidance and strategic advice regarding regulation and coverage of medical devices, including diagnostic tests
Filing targets: Bureau of Industry and Security (BIS), Commerce, Dept of (DOC), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Intl Trade Administration (ITA), SENATE, Treasury, Dept of, U.S. Trade Representative (USTR), White House Office
SENIOR CARE PHARMACY COALITION via BGR GOVERNMENT AFFAIRS
2026 · second_quarter · Q2
Legislation and regulations affecting the long-term care pharmacy industry and guidance on H.R. 5031/ S.3159 Preserving Patient Access to Long-Term Care Pharmacies Act
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, White House Office
COLORECTAL CANCER ALLIANCE via BGR GOVERNMENT AFFAIRS
2026 · second_quarter · Q2
Provide strategic counsel and advocate on issues related to colorectal cancer research and funding
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, White House Office
ACADEMY OF NUTRITION AND DIETETICS via BGR GOVERNMENT AFFAIRS
2026 · second_quarter · Q2
Provide strategic counsel and advocate on issues related to health care coverage for Medical Nutritional Therapy and Intensive behavior health and other priorities for the Academy of Nutrition and Dietetics
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
ALKERMES, INC. via BGR GOVERNMENT AFFAIRS
2026 · second_quarter · Q2
Provide strategic counsel and advocate on issues related to the biopharmaceutical industry generally, and Alkermes, Inc. specifically
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
BREAKTHROUGH T1D (F/K/A JDRF) via BGR GOVERNMENT AFFAIRS
2026 · second_quarter · Q2
Provide strategic counsel and advocate on issues related to Type 1 Diabetes policy
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
ADVOCATE HEALTH via BGR GOVERNMENT AFFAIRS
2026 · second_quarter · Q2
Provide strategic counsel and advocate on health care policy, including matters impacting the hospital industry and federal appropriations
Provide strategic counsel and advocate on health care policy, including matters impacting the hospital industry and federal appropriations
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
INDUCTIVEHEALTH INFORMATICS via BGR GOVERNMENT AFFAIRS
2026 · second_quarter · Q2
Provide strategic counsel and advocate on issues related to expanding support for modern disease and syndromic surveillance, immunization, and chronic disease infrastructure and technology.
Filing targets: Centers For Disease Control & Prevention (CDC), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE